Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM

Go back to Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM
(NASDAQ: NTRA) Delayed: 391.16 -22.22 (5.38%)
Previous Close $413.38    52 Week High $13.80 
Open $408.47    52 Week Low $6.52 
Day High $416.00    P/E N/A 
Day Low $383.76    EPS $0.00 
Volume 971,150